Rankings
▼
Calendar
CRIS Q3 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$15M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+3.5% YoY
Gross Profit
$3M
99.2% margin
Operating Income
-$11M
-360.5% margin
Net Income
-$10M
-344.3% margin
EPS (Diluted)
$-1.70
QoQ Revenue Growth
+15.1%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$42M
Total Liabilities
$51M
Stockholders' Equity
-$9M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$3M
+3.5%
Gross Profit
$3M
$3M
+4.9%
Operating Income
-$11M
-$12M
+14.6%
Net Income
-$10M
-$12M
+17.1%
← FY 2024
All Quarters
Q4 2024 →